PMID- 26160873
OWN - NLM
STAT- MEDLINE
DCOM- 20160819
LR  - 20220408
IS  - 1399-3003 (Electronic)
IS  - 0903-1936 (Linking)
VI  - 46
IP  - 4
DP  - 2015 Oct
TI  - An official European Respiratory Society/American Thoracic Society research 
      statement: interstitial pneumonia with autoimmune features.
PG  - 976-87
LID - 10.1183/13993003.00150-2015 [doi]
AB  - Many patients with an idiopathic interstitial pneumonia (IIP) have clinical 
      features that suggest an underlying autoimmune process but do not meet 
      established criteria for a connective tissue disease (CTD). Researchers have 
      proposed differing criteria and terms to describe these patients, and lack of 
      consensus over nomenclature and classification limits the ability to conduct 
      prospective studies of a uniform cohort.The "European Respiratory 
      Society/American Thoracic Society Task Force on Undifferentiated Forms of 
      Connective Tissue Disease-associated Interstitial Lung Disease" was formed to 
      create consensus regarding the nomenclature and classification criteria for 
      patients with IIP and features of autoimmunity.The task force proposes the term 
      "interstitial pneumonia with autoimmune features" (IPAF) and offers 
      classification criteria organised around the presence of a combination of 
      features from three domains: a clinical domain consisting of specific 
      extra-thoracic features, a serologic domain consisting of specific 
      autoantibodies, and a morphologic domain consisting of specific chest imaging, 
      histopathologic or pulmonary physiologic features.A designation of IPAF should be 
      used to identify individuals with IIP and features suggestive of, but not 
      definitive for, a CTD. With IPAF, a sound platform has been provided from which 
      to launch the requisite future research investigations of a more uniform cohort.
CI  - Copyright (c)ERS 2015.
FAU - Fischer, Aryeh
AU  - Fischer A
AD  - Dept of Medicine, University of Colorado School of Medicine, Denver, CO, USA Task 
      force chair Members of the writing group of the task force 
      aryeh.fischer@ucdenver.edu.
FAU - Antoniou, Katerina M
AU  - Antoniou KM
AD  - Thoracic Medicine, University of Crete, Heraklion, Greece.
FAU - Brown, Kevin K
AU  - Brown KK
AD  - Dept of Medicine, National Jewish Health, Denver, CO, USA.
FAU - Cadranel, Jacques
AU  - Cadranel J
AD  - Pneumologie, Hopital Tenon, Paris, France.
FAU - Corte, Tamera J
AU  - Corte TJ
AD  - The Aldred Hospital, Melbourne, Australia Members of the writing group of the 
      task force.
FAU - du Bois, Roland M
AU  - du Bois RM
AD  - Interstitial Lung Disease Unit, Dept of Occupational Medicine, Royal Brompton 
      Hospital, London, UK.
FAU - Lee, Joyce S
AU  - Lee JS
AD  - Medicine, University of California San Francisco, San Francisco, CA, USA Members 
      of the writing group of the task force.
FAU - Leslie, Kevin O
AU  - Leslie KO
AD  - Pathology, Mayo Clinic, Scottsdale, AZ, USA.
FAU - Lynch, David A
AU  - Lynch DA
AD  - Dept of Radiology, National Jewish Health, Denver, CO, USA.
FAU - Matteson, Eric L
AU  - Matteson EL
AD  - Division of Rheumatology, Mayo College of Medicine, Rochester, MN, USA.
FAU - Mosca, Marta
AU  - Mosca M
AD  - University of Pisa, Pisa, Italy.
FAU - Noth, Imre
AU  - Noth I
AD  - Medicine, University of Chicago, Chicago, IL, USA.
FAU - Richeldi, Luca
AU  - Richeldi L
AD  - Southampton General Hospital, Southampton, UK.
FAU - Strek, Mary E
AU  - Strek ME
AD  - Medicine, University of Chicago, Chicago, IL, USA Members of the writing group of 
      the task force.
FAU - Swigris, Jeffrey J
AU  - Swigris JJ
AD  - Dept of Medicine, National Jewish Health, Denver, CO, USA Members of the writing 
      group of the task force.
FAU - Wells, Athol U
AU  - Wells AU
AD  - Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
FAU - West, Sterling G
AU  - West SG
AD  - University of Colorado School of Medicine, Aurora, CO, USA.
FAU - Collard, Harold R
AU  - Collard HR
AD  - Medicine, University of California San Francisco, San Francisco, CA, USA Members 
      of the writing group of the task force Task force vice-chairs, and contributed 
      equally to this manuscript.
FAU - Cottin, Vincent
AU  - Cottin V
AD  - Service de Pneumologie, Hopital L. Pradel, Lyon, France Members of the writing 
      group of the task force Task force vice-chairs, and contributed equally to this 
      manuscript.
CN  - "ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD"
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150709
PL  - England
TA  - Eur Respir J
JT  - The European respiratory journal
JID - 8803460
RN  - 0 (Autoantibodies)
SB  - IM
CIN - Eur Respir J. 2016 Apr;47(4):1293-5. PMID: 27037322
CIN - Eur Respir J. 2016 Apr;47(4):1295-6. PMID: 27037323
MH  - Autoantibodies/chemistry
MH  - Autoimmune Diseases/*diagnosis/therapy
MH  - Autoimmunity
MH  - Connective Tissue Diseases/immunology
MH  - Europe
MH  - Humans
MH  - Idiopathic Interstitial Pneumonias/*diagnosis/immunology/*therapy
MH  - Lung Diseases, Interstitial/*diagnosis/immunology/*therapy
MH  - Prospective Studies
MH  - Pulmonary Medicine/*standards
MH  - Societies, Medical
MH  - United States
EDAT- 2015/07/15 06:00
MHDA- 2016/08/20 06:00
CRDT- 2015/07/11 06:00
PHST- 2015/01/27 00:00 [received]
PHST- 2015/05/11 00:00 [accepted]
PHST- 2015/07/11 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/08/20 06:00 [medline]
AID - 13993003.00150-2015 [pii]
AID - 10.1183/13993003.00150-2015 [doi]
PST - ppublish
SO  - Eur Respir J. 2015 Oct;46(4):976-87. doi: 10.1183/13993003.00150-2015. Epub 2015 
      Jul 9.